2015ASCO乳腺癌内分泌治疗进展.ppt

谢谢您的关注！！ 3104P2003-2006 * 不同类型双磷酸盐辅助性全身治疗乳腺癌无显著差异，尽管毒性有别，但是各组间差异较小 狄诺塞麦辅助治疗可显著降低接受 AI 治疗的绝经后乳腺癌患者的骨折次数并提高患者骨密度且安全性良好 * Treatment Summary Presented By Nicholas Turner at 2015 ASCO Annual Meeting 治疗情况汇总 Primary Endpoint: PFS (ITT Population) Presented By Nicholas Turner at 2015 ASCO Annual Meeting Slide 16 Presented By Nicholas Turner at 2015 ASCO Annual Meeting Summary of Key Secondary Efficacy Endpoints Presented By Nicholas Turner at 2015 ASCO Annual Meeting 次要疗效终点汇总 Adverse Events—All Cause Presented By Nicholas Turner at 2015 ASCO Annual Meeting 不良反应 Summary of Adverse Events Presented B